SEC Form 4 · accession 0000899243-17-029484
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendy L Yarno
Director
Period of report
Dec 21, 2017
Accepted (ET)
Dec 22, 2017 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $38.55 | Dec 21, 2017 | A | 30,000 | A | — | Dec 20, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The shares vest and become exercisable in 36 equal monthly installments, with the first installment on January 21, 2018. This option is subject to accelerated vesting upon a change of control of the Issuer.